Business News
Home > Business News
FDA approves remdesivir as emergency use for coronavirus treatment
TIWN
TIWN
PHOTO : TIWN
New York, May 7 (New York Post): The Food and Drug Administration on Friday approved the emergency use of remdesivir, an experimental drug that is being tested in treating patients with coronavirus.
The Food and Drug Administration on Friday approved the emergency use of remdesivir, an experimental drug that is being tested in treating patients with coronavirus.
A federal trial that showed that treatment with the anti-viral drug could speed recovery in patients infected with COVID-19.
President Trump made the announcement from the White House with the drugmaker Gilead Sciences’ CEO Dan O’Day.
“I’m pleased to announce that Gilead now has an emergency waiver from the FDA for remdesivir. And you know what that is because that’s been the hot thing, also in the papers and in the media for the last little while — an important treatment for hospitalized coronavirus patients,” Trump said.
He said he had spoken to White House Coronavirus Task Force members Drs. Anthony Fauci and Deborah Birx and FDA chief Stephen Hahn and that they had agreed it was a “promising situation.”
Add your Comment
Comments (0)
More Business News
- With April series having expired, expect markets to turn volatile
- IMF expects India to rev up global growth as China falters, backs Modi government's economic policies
- realme set to shake up market: Launching fastest entry-level 5G smartphone 'C65' under Rs 10k
- India's industrial production accelerates to 5.7pc in Feb
- India records 17 pc jump to become 4th largest exporter of digital services: WTO report
Special Articles
Sanjay Majumder
Anirban Mitra